brain.studio

Middle frontal gyrus (DLPFC)

Gyrus frontalis medius

cortical

The long horizontal gyrus running between the superior and inferior frontal sulci, occupying the middle band of the lateral frontal lobe. Continues anteriorly with the frontal pole and posteriorly with the precentral gyrus. The dorsal segment of the middle frontal gyrus carries the dorsolateral prefrontal cortex (DLPFC), corresponding to Brodmann areas 9 and 46.

DLPFC is the cortical seat of working memory and cognitive control. It is engaged by tasks that require maintenance of information across a delay, manipulation of that information, and selection between competing response options. Working-memory load reliably modulates DLPFC activity on fMRI in a parametric fashion, providing one of the most robust task-evoked signals in cognitive neuroscience.

DLPFC is also a hub of the frontoparietal control network, which is engaged during goal-directed behaviour requiring active maintenance of a task set. This network is contrasted with the cingulo-opercular network for task maintenance, and with the default-mode network whose activity DLPFC suppresses during demanding cognitive tasks.

frontoparietal-control

Patricia Goldman-Rakic’s primate microelectrode work in the 1980s and 1990s identified persistent neuronal firing in dorsolateral prefrontal cortex during the delay period of working-memory tasks. This delay-activity, sustained for seconds at a time without sensory input, provided the cellular substrate for behavioural working memory and established DLPFC as the most-studied cortical correlate of “thought” in the modern neuroscience era.

Miller and Cohen’s 2001 integrative theory placed DLPFC at the apex of cognitive control, with top-down signals to other cortical regions biasing competition in favour of goal-relevant representations. The theory has held up well: DLPFC activity correlates with task-set maintenance across an enormous variety of paradigms, and the strength of this maintenance signal predicts performance.

The clinical impact of these basic-science findings is most visible in psychiatry. Repetitive transcranial magnetic stimulation of left DLPFC was FDA-approved for treatment-resistant depression in 2008, on the basis that hypoactive left DLPFC is a reproducible imaging finding in depression and that experimentally upregulating DLPFC activity produces clinical benefit. Similar protocols are being trialled for OCD, PTSD, and substance-use disorders.